Designed to simultaneously detect 14 of the most prevalent allelic variants associated with alpha-1 antitrypsin deficiency.
The American and European Thoracic/Respiratory Societies (ATS/ERS) recommend that all chronic obstructive pulmonary disease (COPD) patients be tested for AATD as AATD remains highly underdiagnosed. Test for simultaneous multiplex reaction in a single well.
Main benefits
Convenient
Test a high-throughput with up to 192 tests validated on saliva, dry blood spot and whole blood samples.
Innovative technology
Test with a combination of reagents and software based on innovative luminex technology and get automated reports.
14 allelic variants detected
Detect 14 of the most prevalent allelic variants associated with AATD.